Trouble logging in? Forgot password? We can help!
215-685-6784
215-238-6944
Fill out both forms, then either email or fax them to us at the contact above.
Provider? Stay in the know
Get the newest information from the Immunization Program right in your inbox!
Sign upBeyfortus (Nirsevimab) Availability & Inventory Management VFC ordering for the 2024 - 2025 Beyfortus (nirsevimab) season will begin this week.The CDC is releasing VFC Beyfortus (nirsevimab) in waves throughout the 2024-2025 season. Since a limited number of doses will be available in each wave, the Immunization Program will work with...
2024-2025 VFC COVID-19 Product Availability VFC providers can order Moderna and Pfizer 2024-2025 COVID-19 products for all ages beginning on September 9 at 12pm. Make sure that your EHR/EMR is set-up to report this year’s COVID-19 products. These are the vaccines available this year: When placing COVID-19 orders, please...
Flu Vaccine is Available to Order for VFC Flulaval pre-filled syringes and Fluzone multi-dose vials (MDV) are now available to order for your VFC-eligible patients. Visit our website for instructions on how to place your first order: Visit the website Have questions? Email the Ordering team at DPHProviderHelp@phila.gov. ...
2024 -2025 VFC & VFAAR Flu Products 2024-2025 VFC & VFAAR products will be available to order soon. Make sure your office is ready! Flulaval will be available to order for your VFC-eligible patients starting Tuesday, August 20, 2024. Start the conversation about the importance of flu vaccination...
Vaccine Product Available Through VFC: Jynneos Jynneos (Bavarian Nordic) vaccine is now available through the VFC program. It has been approved and recommended by the CDC and ACIP to prevent mpox (formerly monkeypox). VFC-eligible patients, 18 years of age only, can be vaccinated with these doses. Patients...
Remind Families About Back to School Vaccines Prepare your pediatric patients to return to school by getting them caught up with their vaccines. Access reminder recall guidance, free print materials, and more information about vaccination coverage rates below. According to CDC, vaccination coverage among kindergarten students...
Return Expired Doses of Flu Today! All VFC/VFAAR influenza vaccines supplied by the Philadelphia Immunization Program during the 2023-2024 flu season have expired. Please account for unused VFC/VFAAR flu vaccine at your site using PhilaVax: Process a return for the unopened vials online in the Vaccine Returns...
PhilaVax Temperature Reporting Requirement Update Important: VFC & VFAAR orders submitted to PhilaVax without temperature data will be rejected. * We will no longer contact VFC & VFAAR sites to request missing temperature data after the order date. VFC & VFAAR orders will be rejected, and the...
New Vaccine Product Available Through VFC: Penbraya (MenABCWY) On October 20, 2023, the FDA licensed Pfizer’s pentavalent vaccine Penbraya to prevent meningococcal serogroups A, B, C, W, and Y. As a reminder, MenB vaccines are not interchangeable. The same vaccine (either Bexsero by GSK or Trumenba by...
Congratulations to last week’s survey winner: Puentes De Salud! But wait, there’s another chance to win and help us better prepare for the next flu season! We will hold a second drawing to win a free buzzy. To enter our second drawing, use the button below...
2024 Influenza Ordering Survey While flu remains prevalent across the country, the 2023-2024 flu season has seen a drop in coverage, and Philadelphia is no exception. Fill out this short survey (less than 3 minutes) to help us better prepare for next flu season. Every site...
Pediatric Immunization Techniques Training Join us for a pediatric immunization techniques training for Vaccines for Children (VFC) providers! The Immunization Program is hosting a free pediatric immunization techniques training for VFC providers. Class participants are limited and will be taken on a first-come, first-served basis. A...
Protect Children Against Travel-Associated Infections This blog post was written alongside Dr. Mayssa Abuali, who has served the Philadelphia pediatric community for the past 10 years. There are several measles outbreaks internationally and 58 measles cases have been reported across 17 jurisdictions the United States in 2024. 93% of...
RSV Season Ends March 31 As the respiratory syncytial virus (RSV) season draws to a close on March 31, we want to remind all healthcare providers of important considerations regarding administering nirsevimab (Beyfortus) and RSV immunization. End of RSV season: The RSV season officially concludes on March...
Recommend HPV Vaccine at Every Visit! The HPV vaccine is approved for ages 9 years through 45 years for all genders. The American Cancer Society and American Academy of Pediatrics (AAP) recommend vaccination at age 9. Early vaccination at age 9-10 years has several benefits, including more...
Beyfortus (Nirsevimab) Supply and Borrowing Update The supply of nirsevimab allocated to the Vaccines For Children (VFC) program has been depleted. Therefore, no doses are available to order for the remainder of the 2023-2024 respiratory syncytial virus (RSV) season. As we approach the end of the RSV...
Catch Up Pediatric Patients: MMR Vaccine There is a measles cluster in Philadelphia that started with an infant and spread to unvaccinated individuals. It has resulted in now 7 confirmed cases of measles among Philadelphia residents and an index case in Delaware county.To prevent further spread, review your...
Vaccine Product Available Through VFC: Abrysvo Abrysvo is a maternal RSV vaccine available through the Vaccines for Children (VFC) program. RSV is surging and the pediatric infant immunization Beyfortus supply is severely limited. Abrysvo will play an important role in protecting infants against severe RSV disease this season. Most...
